Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation
Clinical trial NCT03688802 · COMPLETED
Trial details
- NCT number
- NCT03688802
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2019-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.